Jinyu Bio-technology Co., Ltd.
SHH: 600201.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jing Zhang
- Employees
- 1,654
- Headquarters
- Hohhot, China
- IPO year
- 1999
- Market cap
- CN¥16.8B
- Website
- https://www.jinyu.com.cn
Loading 600201…
Loading profile data…Frequently asked questions about 600201
What does Jinyu Bio-technology Co., Ltd. (600201.SS) do?
Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sales of veterinary biological products in China. It offers vaccines for foot-and-mouth disease, highly pathogenic avian influenza, brucellosis, rabies, and swine fever for pigs, poultry, ruminants, and pets. The company was formerly known as Inner Mongolia J...
Where does 600201.SS trade?
Jinyu Bio-technology Co., Ltd. (600201.SS) trades on the Shanghai Stock Exchange.
What sector is 600201.SS in?
Jinyu Bio-technology Co., Ltd. (600201.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Jinyu Bio-technology Co., Ltd.?
Jing Zhang is the chief executive officer of Jinyu Bio-technology Co., Ltd. (600201.SS).
Where is Jinyu Bio-technology Co., Ltd. headquartered?
Jinyu Bio-technology Co., Ltd. is headquartered in China.
Does 600201.SS pay a dividend?
Yes — Jinyu Bio-technology Co., Ltd. (600201.SS) paid a trailing twelve-month dividend of CNY 0.03 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600201.SS go public?
Jinyu Bio-technology Co., Ltd. (600201.SS) completed its initial public offering in 1999.